Cardiff Oncology (NasdaqCM:CRDF) Update / briefing Transcript

Cardiff Oncology (NasdaqCM:CRDF) Update / briefing March 25, 2026 04:30 PM ET Company ParticipantsHeinz-Josef Lenz - University Professor of Medicine, Preventive Medicine, and Cancer BiologyMani Mohindru - Interim CEOScott Kopetz - Professor and Deputy Chair in the Department of Gastrointestinal Medical OncologyConference Call ParticipantsMarc Frahm - Managing Director and Senior Research AnalystMaury Raycroft - Equity Research AnalystModeratorPlease be advised that today's conference is being recorded. I w ...